Clinical trial

Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D

NCT04729296

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2021-07-01

PhasePHASE2

Study timeline

Study start (estimated)2021-07-01Date precision: day

Registry last updated2021-12-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

GolimumabDRUG · verified · RxNorm: golimumab

PlaceboDRUG

Sponsors & collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)lead sponsor

University of South Floridacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04729296 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.